Session sponsor
Concurrent sessions
Explore emerging insights shaping the future of cancer care, from psychosocial outcomes and national data to advances in genomics and rare cancers. This session includes a rapid pitch presentation from Gilead Sciences, alongside research driving innovation in metastatic disease, Cancer of Unknown Primary, and evolving models of personalised care.
| Time | Abstract Title | Presenter |
|---|---|---|
| 16:00 – 16:25 | Rapid pitch presentation (presented by Gilead) | Gilead |
| 16:30 – 16:45 | Profiles of psychological capital and its correlation with coping styles in young and middle-aged patients with advanced lung cancer: A latent profile analysis | Yunxia Hou |
| 16:45 – 17:00 | Counted at last: Australia’s first national metastatic breast cancer prevalence estimate | Vicki Durston |
| 17:00 – 17:15 | Driving national change through interdisciplinary collaboration: SUPER-ED trial transforming care for cancer of unknown primary (CUP) | Sarah McLean |
| 17:15 – 17:30 | Impact and sustainability of extended genetic testing panels in a high-risk breast and ovarian cancer clinic | Trish Calder |